X6Q-12228-82844
2 vaccinations
2 coded responses
4 check-ins
2 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 951 / CA
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-03
Dose 1 — Pfizer-BioNTech
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-03
Registered in v-safe
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-04-06
Survey response — days 1–6 daily, dose 2MedDRA: Hospitalisation, Muscular weakness, Myelitis transverse — Feeling: Fair · Site: Pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Leg weakness and hospitalized for acute transverse myelitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Hospitalisation — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Hospitalized with acute transverse myelitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-03 | priority 2/3 | |
| 2021-04-04 | priority 2/3 | |
| 2021-04-06 | priority 2/3 | |
| 2021-04-07 | priority 2/3 |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Leg weakness and hospitalized for acute transverse myelitis
Systemic reaction (other): Hospitalized with acute transverse myelitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Hospitalisation | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Myelitis transverse | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release